Eidos Therapeutics Inc (EIDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EIDX | AZN | AMGN | GILD | VRTX |
| Company | Eidos Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 127.57 | 196.72 | 376.17 | 147.73 | 482.25 |
| High | 128.49 | 198.09 | 379.26 | 149.38 | 507.92 |
| Low | 116.83 | 194.81 | 372.74 | 146.84 | 477.77 |
| Latest | 122.21 | 194.99 | 375.43 | 148.56 | 499.17 |
| Change | -6.23 | +0.04 | -1.54 | +1.93 | +38.30 |
| % Change | -4.85% | +0.02% | -0.41% | +1.32% | +8.31% |
| Volume | 335,500 | 1,658,200 | 2,284,500 | 5,098,400 | 3,363,800 |
| 20-Day Average Volume | 113,985 | 2,209,405 | 2,662,945 | 7,356,385 | 1,533,175 |
| Previous Close | 128.44 | 194.95 | 376.97 | 146.63 | 460.87 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 124.59 | 202.88 | 375.78 | 149.40 | 475.96 |
| 20-Day Raw Stochastic | 36.63% | 24.14% | 47.64% | 39.88% | 84.72% |
| 20-Day Relative Strength | 56.42 | 48.92 | 56.13 | 56.59 | 58.34 |
| Weighted Alpha | +136.62 | +31.15 | +28.23 | +40.94 | +8.43 |
| Today's Opinion | 88% Buy | 80% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 100% Buy | 80% Buy | 100% Buy | 88% Buy | 64% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.40% since 01/15/21 | -3.36% since 03/03/26 | -0.42% since 03/03/26 | +0.49% since 03/03/26 | +5.25% since 03/03/26 |
| Low | 116.83 on 01/25/21 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 131.08 on 01/20/21 | 203.29 on 03/04/26 | 380.09 on 03/04/26 | 149.38 on 03/10/26 | 507.92 on 03/10/26 |
| 1-Month | |||||
| %Chg | -4.30% since 12/24/20 | +0.82% since 02/10/26 | +2.96% since 02/10/26 | +0.90% since 02/10/26 | +7.70% since 02/10/26 |
| Low | 116.24 on 01/05/21 | 189.35 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 132.54 on 01/04/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 3-Month | |||||
| %Chg | +66.75% since 10/23/20 | +6.54% since 12/10/25 | +19.04% since 12/10/25 | +22.43% since 12/10/25 | +12.26% since 12/10/25 |
| Low | 69.38 on 10/30/20 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 132.54 on 01/04/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | +178.07% since 07/24/20 | +20.65% since 09/10/25 | +34.80% since 09/10/25 | +28.90% since 09/10/25 | +28.47% since 09/10/25 |
| Low | 38.44 on 07/31/20 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 132.54 on 01/04/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,750,670 | 302,349,504 | 203,212,464 | 182,029,584 | 117,076,648 |
| Shares Outstanding, K | 38,873 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 26,690,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -37,840,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 130,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -30,180,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | -0.16 | 0.32 | 0.45 | 0.36 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 02/24/21 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.20 | 16.91 | 17.66 | 27.81 |